(Q48267065)

10 February 2018

title

Vasopressin in Alzheimer's disease: a study of postmortem brain concentrations. (English)

1 reference

10 February 2018

0 references

0 references

3

Bird ED

1 reference

10 February 2018

author name string

Mazurek MF

series ordinal

1

1 reference

10 February 2018

Beal MF

series ordinal

2

1 reference

10 February 2018

Martin JB

series ordinal

4

1 reference

10 February 2018

publication date

1 December 1986

1 reference

10 February 2018

published in

Annals of Neurology

1 reference

10 February 2018

volume

20

1 reference

10 February 2018

issue

6

1 reference

10 February 2018

page(s)

665-670

1 reference

10 February 2018

CSF vasopressin concentration is reduced in Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANA.410200603

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410200603

Identification of the vasopressin-neurophysin II and the oxytocin-neurophysin I producing neurons in the bovine hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410200603

Identification of the vasopressin-neurophysin producing neurons of the rat suprachiasmatic nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410200603

21 January 2018

Identifiers

DOI

10.1002/ANA.410200603

1 reference

10 February 2018

PubMed ID

3813496

1 reference

10 February 2018